These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 10755077)
21. Course of obsessive-compulsive disorder in children and adolescents: a prospective follow-up study of 23 Danish cases. Thomsen PH; Mikkelsen HU J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1432-40. PubMed ID: 8543510 [TBL] [Abstract][Full Text] [Related]
22. [Obsessive-compulsive disorder in children and adolescents and its continuation throughout life]. Liakopoulou M Psychiatriki; 2012 Jun; 23 Suppl 1():101-6. PubMed ID: 22796979 [TBL] [Abstract][Full Text] [Related]
23. Overvalued ideation in adolescents with obsessive-compulsive disorder. Borda T; Neziroglu F; Taboas W; McKay D; Frenkiel L Psychiatry Res; 2017 Sep; 255():66-71. PubMed ID: 28528243 [TBL] [Abstract][Full Text] [Related]
26. [Obsessive-compulsive disorder in children and adolescents: a literature review. Part II]. Bryńska A Psychiatr Pol; 1998; 32(1):77-88. PubMed ID: 9594586 [TBL] [Abstract][Full Text] [Related]
28. Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia. Poyurovsky M; Kriss V; Weisman G; Faragian S; Kurs R; Schneidman M; Fuchs C; Weizman A; Weizman R J Clin Psychiatry; 2003 Nov; 64(11):1300-7. PubMed ID: 14658943 [TBL] [Abstract][Full Text] [Related]
29. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I). Garcia AM; Sapyta JJ; Moore PS; Freeman JB; Franklin ME; March JS; Foa EB J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1024-33; quiz 1086. PubMed ID: 20855047 [TBL] [Abstract][Full Text] [Related]
31. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials? Geller DA; Biederman J; Stewart SE; Mullin B; Farrell C; Wagner KD; Emslie G; Carpenter D J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S19-29. PubMed ID: 12880497 [TBL] [Abstract][Full Text] [Related]
32. Inferential confusion in obsessive-compulsive disorder: the inferential confusion questionnaire. Aardema F; O'Connor KP; Emmelkamp PM; Marchand A; Todorov C Behav Res Ther; 2005 Mar; 43(3):293-308. PubMed ID: 15680927 [TBL] [Abstract][Full Text] [Related]
33. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis. Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090 [TBL] [Abstract][Full Text] [Related]
34. Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. Grados M; Scahill L; Riddle MA Child Adolesc Psychiatr Clin N Am; 1999 Jul; 8(3):617-34, x. PubMed ID: 10442233 [TBL] [Abstract][Full Text] [Related]
35. Metacognitive beliefs predict early response to pharmacological treatment in patients with obsessive-compulsive disorder. Park CI; Kim HW; Jeon S; Hwang EH; Kang JI; Kim SJ Psychopharmacology (Berl); 2020 Nov; 237(11):3489-3496. PubMed ID: 32748029 [TBL] [Abstract][Full Text] [Related]
36. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Pigott TA; Seay SM J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636 [TBL] [Abstract][Full Text] [Related]
37. Obsessions: the impact and treatment of obsessive-compulsive disorder in children and adolescents. Thomsen PH J Psychopharmacol; 2000; 14(2 Suppl 1):S31-37. PubMed ID: 10888029 [TBL] [Abstract][Full Text] [Related]